GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liaoning Chengda Biotechnology Co Ltd (SHSE:688739) » Definitions » EV-to-FCF

Liaoning Chengda Biotechnology Co (SHSE:688739) EV-to-FCF : 47.99 (As of Jun. 07, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Liaoning Chengda Biotechnology Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Liaoning Chengda Biotechnology Co's Enterprise Value is ¥5,255 Mil. Liaoning Chengda Biotechnology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ¥109 Mil. Therefore, Liaoning Chengda Biotechnology Co's EV-to-FCF for today is 47.99.

The historical rank and industry rank for Liaoning Chengda Biotechnology Co's EV-to-FCF or its related term are showing as below:

SHSE:688739' s EV-to-FCF Range Over the Past 10 Years
Min: -12506.41   Med: 72.1   Max: 851.27
Current: 53.02

During the past 11 years, the highest EV-to-FCF of Liaoning Chengda Biotechnology Co was 851.27. The lowest was -12506.41. And the median was 72.10.

SHSE:688739's EV-to-FCF is ranked worse than
81.05% of 380 companies
in the Biotechnology industry
Industry Median: 8.375 vs SHSE:688739: 53.02

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-07), Liaoning Chengda Biotechnology Co's stock price is ¥25.90. Liaoning Chengda Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.010. Therefore, Liaoning Chengda Biotechnology Co's PE Ratio for today is 25.64.


Liaoning Chengda Biotechnology Co EV-to-FCF Historical Data

The historical data trend for Liaoning Chengda Biotechnology Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Liaoning Chengda Biotechnology Co EV-to-FCF Chart

Liaoning Chengda Biotechnology Co Annual Data
Trend Dec13 Dec14 Dec15 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -12,987.38 197.60 63.32

Liaoning Chengda Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.48 69.97 92.86 63.32 56.36

Competitive Comparison of Liaoning Chengda Biotechnology Co's EV-to-FCF

For the Biotechnology subindustry, Liaoning Chengda Biotechnology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Liaoning Chengda Biotechnology Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Liaoning Chengda Biotechnology Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Liaoning Chengda Biotechnology Co's EV-to-FCF falls into.



Liaoning Chengda Biotechnology Co EV-to-FCF Calculation

Liaoning Chengda Biotechnology Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=5255.258/109.496
=47.99

Liaoning Chengda Biotechnology Co's current Enterprise Value is ¥5,255 Mil.
Liaoning Chengda Biotechnology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥109 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Liaoning Chengda Biotechnology Co  (SHSE:688739) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Liaoning Chengda Biotechnology Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=25.90/1.010
=25.64

Liaoning Chengda Biotechnology Co's share price for today is ¥25.90.
Liaoning Chengda Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.010.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Liaoning Chengda Biotechnology Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Liaoning Chengda Biotechnology Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Liaoning Chengda Biotechnology Co (SHSE:688739) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Xinfang Street, Hunnan New District, Liaoning Province, Shenyang, CHN, 110179
Liaoning Chengda Biotechnology Co Ltd is engaged in the research and development, production and sales of human vaccines.
Executives
Li Ning Director
Cui Jian Wei senior management
Chen Xin senior management
Zhang Shu Min Director
Zhou Li Bao senior management
Yuan De Ming senior management
Gao Jun Director
Yang Xu Director

Liaoning Chengda Biotechnology Co (SHSE:688739) Headlines

No Headlines